Inventor · disambiguated record
Eckhard Gunther
Also filed as: GUENTHER ECKHARD · GUNTHER ECKHARD
27 granted patents·10 pending applications·434 citations·filing 1996–2010
96Inventor score
Top patents by PatentIndex Score
37 records- 0195US7026310B2Heteroaryl derivatives and their use as medicamentsZENTARIS GMBH·Filed 2005·Granted Apr 11, 2006·39 cites·14 claims
- 0293US6638935B2Heteroary1 derivatives and their use as medicamentsZENTARIS AG·Filed 2001·Granted Oct 28, 2003·54 cites·48 claims
- 0392US7056912B2Heteroaryl derivatives and their use as medicamentsZENTARIS GMBH·Filed 2003·Granted Jun 6, 2006·41 cites·15 claims
- 0492US6936615B2Heteroaryl derivatives and their use as medicamentsZENTARIS GMBH·Filed 2003·Granted Aug 30, 2005·38 cites·14 claims
- 0592US6890926B2Heteroaryl derivatives and their use as medicamentsZENTARIS AG·Filed 2001·Granted May 10, 2005·39 cites·13 claims
- 0691US6232327B1Indolyl-3-glyoxylic acid derivatives having antitumor actionASTA MEDICA AG·Filed 1999·Granted May 15, 2001·78 cites·5 claims
- 0788US6706722B2Heteroaryl derivatives and their use as medicamentsZENTARIS AG·Filed 2001·Granted Mar 16, 2004·55 cites·10 claims
- 0886US6432987B2Substituted N-benzylindol-3-ylglyoxylic acid derivatives having antitumor actionZENTARIS AG·Filed 2000·Granted Aug 13, 2002·32 cites·10 claims
- 0976US6627609B1LHRH antagonists having improved solubility propertiesZENTARIS AG·Filed 2000·Granted Sep 30, 2003·9 cites·14 claims
- 1075US7211588B2N-substituted indolyl-3-glyoxylamides, their use as medicaments and process for their preparationZENTARIS GMBH·Filed 2004·Granted May 1, 2007·7 cites·12 claims
- 1175US7205299B2Indole derivatives having an apoptosis-inducing effectZENTARIS GMBH·Filed 2004·Granted Apr 17, 2007·7 cites·21 claims
- 1273US7579365B2Indolyl-3-glyoxylic acid derivatives having antitumor actionZIOPHARM ONCOLOGY INC·Filed 2002·Granted Aug 25, 2009·5 cites·13 claims
- 1370US7276507B2Pyridopyrazines and the use thereof as kinase inhibitorsAETERNA ZENTARIS GMBH·Filed 2004·Granted Oct 2, 2007·7 cites·8 claims
- 1469US7323468B2Pyridopyrazines and the use thereof as kinase inhibitorsAETERNA ZENTARIS GMBH·Filed 2004·Granted Jan 29, 2008·5 cites·8 claims
- 1568US7365081B2Indole derivatives and their use as medicamentsAETERNA ZENTARIS GMBH·Filed 2001·Granted Apr 29, 2008·4 cites·9 claims
- 1667US8067456B2Tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCPs)PAULINI KLAUS·Filed 2008·Granted Nov 29, 2011·2 cites·9 claims
- 1766US7148195B2LHRH antagonists having improved solubility propertiesZENTARIS GMBH·Filed 2003·Granted Dec 12, 2006·2 cites·4 claims
- 1865US8193186B2Pyridopyrazines and the use thereof as kinase inhibitorsSEIPELT IRENE·Filed 2007·Granted Jun 5, 2012·1 cites·9 claims
- 1963US7375127B2Tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCRs)AE ZENTARIS GMBH·Filed 2005·Granted May 20, 2008·1 cites·31 claims
- 2062US2008027110A1Indolyl-3-glyoxylic acid derivatives having antitumor actionASTA MEDICA AG·Filed 2007·Application pending·0 cites
- 2161US8008324B2Indole derivatives and their use as medicamentAETERNA ZENTARIS GMBH·Filed 2008·Granted Aug 30, 2011·0 cites·11 claims
- 2260US8389497B2Use of alkylphosphocholines in combination with antitumor medications for the treatment of benign and malignant oncoses in humans and mammalsENGEL JUERGEN·Filed 2003·Granted Mar 5, 2013·0 cites·5 claims
- 2359US7989453B2Indole derivatives and their use as medicamentAETERNA ZENTARIS GMBH·Filed 2007·Granted Aug 2, 2011·0 cites·2 claims
- 2458US7732412B2Methods of treatment using novel LHRH antagonists having improved solubility propertiesZENTARIS GMBH·Filed 2006·Granted Jun 8, 2010·0 cites·8 claims
- 2558US2005245523A1Heteroaryl derivatives and their use as medicamentsZENTARIS GMBH·Filed 2005·Application pending·0 cites
- 2658US2009311264A1Use of Disorazoles and Their Derivatives for the Treatment of Benign and Malignant OncosesAETERNA ZENTARIS GMBH·Filed 2009·Application pending·0 cites
- 2757US8551977B2Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammalsENGEL JUERGEN·Filed 2010·Granted Oct 8, 2013·0 cites·19 claims
- 2857US8507710B2Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammalsENGEL JUERGEN·Filed 2010·Granted Aug 13, 2013·0 cites·6 claims
- 2957US2008113991A1Pyridopyrazines and the use thereof as kinase inhibitorsZENTARIS GMBH·Filed 2007·Application pending·0 cites
- 3050US2003023093A1United states patent officeASTA MEDICA AG·Filed 2001·Application pending·0 cites
- 3149US2004106662A1Use of the disorazoles and their derivatives for the treatment of benign and malignant oncosesFiled 2003·Application pending·0 cites
- 3247US5747534ALobaplatin trihydrateASTA MEDICA AG·Filed 1996·Granted May 5, 1998·8 cites·6 claims
- 3343US2005009809A1Acridine derivatives and their use as medicamentsFiled 2004·Application pending·0 cites
- 3441US2004110756A1New anthracene derivatives and their use as pharmaceutical preparationsFiled 2003·Application pending·0 cites
- 3541US2008051463A1Anthracene compounds and their use for treating benign and malignant tumor disordersAETERNA ZENTARIS GMBH·Filed 2007·Application pending·0 cites
- 3640US8383605B2Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammalsAETERNA ZENTARIS GMBH·Filed 2010·Granted Feb 26, 2013·0 cites·9 claims
- 3739US2004097734A1Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncosesFiled 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →